| __timestamp | Corcept Therapeutics Incorporated | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 19586000 |
| Thursday, January 1, 2015 | 15419000 | 29135000 |
| Friday, January 1, 2016 | 23844000 | 42791000 |
| Sunday, January 1, 2017 | 40376000 | 49577000 |
| Monday, January 1, 2018 | 75247000 | 89209000 |
| Tuesday, January 1, 2019 | 89017000 | 69099000 |
| Wednesday, January 1, 2020 | 114764000 | 75961000 |
| Friday, January 1, 2021 | 113864000 | 90467000 |
| Saturday, January 1, 2022 | 130991000 | 74552000 |
| Sunday, January 1, 2023 | 184353000 | 91593000 |
Infusing magic into the data realm
In the competitive world of biopharmaceuticals, strategic allocation of research and development (R&D) funds is crucial for innovation and growth. Over the past decade, Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. have demonstrated distinct approaches to R&D investment. From 2014 to 2023, Corcept Therapeutics increased its R&D spending by an impressive 900%, peaking in 2023. This surge underscores their commitment to advancing therapeutic solutions. Meanwhile, Supernus Pharmaceuticals exhibited a more stable growth pattern, with a 370% increase over the same period, reflecting a balanced approach to innovation and market expansion. Notably, in 2023, Corcept's R&D expenses were double those of Supernus, highlighting their aggressive investment strategy. These trends not only reveal the companies' priorities but also provide insights into the evolving landscape of pharmaceutical innovation.
Analyzing R&D Budgets: Sanofi vs Corcept Therapeutics Incorporated
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.